0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Eligard]

RxCUI: 825335
RxNorm name: 0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Eligard]
Display name: 0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Eligard]
Full name: 0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Eligard]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Eligard	LEUPROLIDE ACETATE	TOLMAR Inc.	b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	2026-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 825335
ELIGARD	LEUPROLIDE ACETATE	TOLMAR Inc.	b78d1919-9dee-44fa-90f9-e0a26d32481d	2019-04-29	Warnings, Adverse reactions	Exact identifier rxcui: 825335

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
b78d1919-9dee-44fa-90f9-e0a26d32481d	0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Eligard]	SBD	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b78d1919-9dee-44fa-90f9-e0a26d32481d	Eligard 22.5 MG in 0.375 ML (3 month) Prefilled Syringe	PSN	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b78d1919-9dee-44fa-90f9-e0a26d32481d	0.375 ML Eligard 60 MG/ML Prefilled Syringe	SY	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b78d1919-9dee-44fa-90f9-e0a26d32481d	Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe	SY	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b78d1919-9dee-44fa-90f9-e0a26d32481d	Eligard 22.5 MG per 0.375 ML Prefilled Syringe	SY	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe	SY	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	Eligard 22.5 MG per 0.375 ML Prefilled Syringe	SY	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	0.375 ML Eligard 60 MG/ML Prefilled Syringe	SY	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	0.375 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Eligard]	SBD	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	Eligard 22.5 MG in 0.375 ML (3 month) Prefilled Syringe	PSN	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430